{
  "docId": "019de075-3db6-70cc-be39-8d329d3330a5",
  "docSlug": "9a5a1cb2d23439a1f3fda2d5175b10b5",
  "documentTitle": "Alkermes | Results Presentation Deck | 17 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 10,
  "pageCount": 17,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 4,
  "notes": "The chart displays both weekly data and a 4-week rolling average.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-3db6-70cc-be39-8d329d3330a5/10",
  "deckHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5",
  "deckJsonHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5.json",
  "deckAnchorHref": "/decks/019de075-3db6-70cc-be39-8d329d3330a5#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.65,
        "x": 0.05,
        "y": 0.235
      },
      "kind": "chart",
      "text": "Post-Launch TRx* (Through 7/14/23)",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "debf9c3e-0d48-468e-9f18-b2e9b6edf089",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.25,
        "x": 0.7,
        "y": 0.35
      },
      "kind": "list",
      "text": "~38,300 reflecting 16% sequential growth compared to Q1'23",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bd877154-d163-466d-b5f1-1c64bbcb7d50",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.25,
        "x": 0.7,
        "y": 0.5
      },
      "kind": "paragraph",
      "text": "~11,150 prescribers had written a prescription for LYBALVI (as of 6/30/23) since launch",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "be3d358f-5b76-48e1-b6fa-a6b771bab360",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.15,
        "x": 0.05,
        "y": 0.88
      },
      "kind": "source-note",
      "text": "*Source: IQVIA NPA Weekly",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "997ffe42-82d3-4691-825e-7f1c816bd090",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.05,
        "y": 0.12
      },
      "kind": "title",
      "text": "LYBALVI® Prescription Growth Trends",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e0b88c7d-3af0-43c8-957b-c45ab5e4090b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 13,
      "from": 4,
      "beatId": "d5f4e08a-d337-402e-8a2b-d07acbe069eb",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Key Performance Indicator Overview",
      "beatSlug": null,
      "evidence": "Slides 4-13 provide an overview of the company's financial results, revenue summary, and product performance.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 11,
      "from": 7,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "7aacdd12-f2ee-4912-b182-10d9fd1385f9",
      "evidence": "The presentation highlights the company's topline growth and diversification, implying that not achieving this growth would have negative consequences.",
      "position": 0,
      "objective": "What are the implications of not achieving topline growth and diversification?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 11,
      "from": 9,
      "name": "Voice Of Customer",
      "slug": "51-voice-of-customer",
      "bestFor": "Product strategy, customer experience, market research",
      "matchId": "d07d2911-1274-4deb-8262-177be0bf2ba5",
      "evidence": "Slides 9-11 provide an overview of LYBALVI prescription growth trends, implying that customer feedback and market data are driving the company's commercial strategies.",
      "position": 1,
      "objective": "What do customers think about LYBALVI prescription growth trends?",
      "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response",
      "confidence": 0.6,
      "description": "Let customer quotes and feedback drive the narrative and validate the insight"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}